IMPAC3T-IP is an ambitious Coordination and Support Action that aims to develop, pilot and support the sustainable adoption of a scenario based licensing ToolBox through a certified user and trainer programme, for efficient IP licensing for market uptake and societal value creation. This document is an output of Work Package 2: Scenario definition and process mapping.
Discover how the Creative Launch Fund, a joint initiative by the University of Glasgow, the Glasgow School of Art, and The Royal Conservatoire of Scotland, supports innovation in the Arts and Humanities through training and funding for impactful research projects.
Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success. Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements.
The INNOV-8-2-CREATE Toolkit is designed to enable universities, innovation hubs, and stakeholders across Europe to replicate the pre-accelerator programme effectively. In addition to providing step-by-step guidance, templates, and examples, the toolkit ensures the programme's sustainability, inclusivity, and scalability.
Starting from humble beginnings, China has emerged as the world's largest patent filer and is becoming an IP powerhouse. According to the WIPO's Global Innovation Index 2024, China ranks 11th of the world's most innovative economies, and the Chinese government has pledged leveraging intellectual property to boost innovation and economic growth. This also points to the flipside of the medal, namely a centralised institution with a top-down approach to governance. This webinar explores some practical aspects of the two overlapping impressions, or a “tale of two countries”.
The Digital Innovations SIG webinar explores software compliance with open-source licensing, focusing on ensuring ownership and avoiding third-party rights conflicts. Discussions include the use, development, and implementation of software repositories, their challenges, and benefits for licensing and commercial opportunities. Participants share insights and best practices for effective repository management.
In 2024, Tanja Kovačič presents The Impact Fund of the University of Ljubljana – The HUD Fund in a webinar organised by SHAPE SIG. She highlights the fund’s role in enhancing social sciences, arts, and humanities research impact and explores recent knowledge transfer activities leading to its creation.
Join Katrina Bradley and BioMedical SIG for a webinar on market access strategies in life sciences. Learn to plan, execute, and optimise early tech deployment.
In 2024, Nicoline Løvenskjold Guldsing presents Innovative SHAPE Developments in Denmark in a webinar organised by SHAPE SIG. She discusses the Danish SHAPE Taskforce’s collaborative strategy, new initiatives supporting SHAPE, and insights from her work at the University of Southern Denmark.
Second webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences. This webinar will focus on the process involved with the release of new medical devices.
In 2024, Professor Roberta Guerrina presents Different Routes to Impact for SHAPE Research in a webinar organised by SHAPE SIG. She shares her experience combining spinouts, consultancy, and policy, highlighting her work with EQUAL In-Sight, a platform promoting equality through evidence-based, data-driven solutions for organisations.
In this webinar Sjaak Brinkkemper presents his vision on entrepreneurship in ecosystems: starting a software company is relatively easy, but continuing the enterprise in a solid and sustainable manner is extremely difficult. He investigates decision making on software production: product roadmapping, product/service duality, customer involvement, productisation, and internationalisation. He also pays attention to the role of the Knowledge Transfer Office in the ecosystem in a very early stage.
Join our newsletter and get the latest news